Key result
Women are less likely than men to receive guideline-based care for heart disease and dyslipidemia, necessitating revised practice patterns to improve cardiovascular outcomes.
Addressing the suboptimal recognition and treatment of lipid abnormalities in women is critical to improving their cardiovascular outcomes.
Answers are grounded in this paper and cite their sources.
Persistent sex disparities in care warrant clinician vigilance; leaves open effective equity interventions.
Gender differences in the treatment of heart disease have a significant impact on the outcomes and mortality for women. From screening and detection, through treatment and intervention, women are less likely than men to receive guideline-based care. Risk factor modification, including lipid management, is critical to all levels of prevention. This article discusses gender differences in the detection and management of dyslipidemia. By identifying the suboptimal recognition and treatment of lipid abnormalities in women, healthcare professionals can revise their practice patterns in an effort to improve the outcomes for women with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Kelly J. Trynosky (2006) conducted a review in Heart disease and dyslipidemia. Women are less likely than men to receive guideline-based care for heart disease and dyslipidemia, necessitating revised practice patterns to improve cardiovascular outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: